Literature DB >> 3677336

Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation.

I Biaggioni1, B Olafsson, R M Robertson, A S Hollister, D Robertson.   

Abstract

The cardiovascular and respiratory effects of intravenous adenosine were studied in conscious normal volunteers. Bolus injections of adenosine increased systolic and diastolic pressures initially (+15 and +13 mm Hg after 100 micrograms/kg) followed by a subsequent reduction in systolic and diastolic pressures (-12 and -16 mm Hg). Heart rate increased during trough blood pressure (R-R interval shortening of 298 msec after 100 micrograms/kg). Adenosine steady-state infusions increased heart rate (+30 beats/min during 140 micrograms/kg/min), systolic pressure (+16 mm Hg), and pulse pressure (+21 mm Hg) but decreased diastolic pressure slightly (-5 mm Hg), resulting in no significant change in mean arterial pressure. Adenosine stimulated respiration, resulting in decreased PaCO2 (41 to 31 mm Hg), increased PaCO2 (101 to 113 mm Hg), and increased pH (7.42 to 7.50). The increased ventilation was not explained by bronchoconstriction, hypotension, or hypoxia. The observed pressor and tachycardic effects are mediated through reflex autonomic mechanisms since they are completely abolished in patients with severe autonomic failure. These autonomic mechanisms probably involve chemoreceptor activation since adenosine is pressor when infused in the aortic arch proximal to the origin of the carotid arteries but depressor when infused in the descending aorta. It is concluded that the hemodynamic and respiratory effects of adenosine observed in normal volunteers are in part due to chemoreceptor stimulation. These findings raise the possibility that adenosine is an endogenous modulator of respiration in man.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677336     DOI: 10.1161/01.res.61.6.779

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  43 in total

Review 1.  The role of adenosine in neurogenic syncope: much ado about something?

Authors:  I Biaggioni
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

2.  Carotid body function in aged rats: responses to hypoxia, ischemia, dopamine, and adenosine.

Authors:  Teresa Castro Monteiro; Joana Rita Batuca; Ana Obeso; Constancio González; Emília Carreira Monteiro
Journal:  Age (Dordr)       Date:  2010-10-05

3.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

4.  Adenosine deaminase and adenosine uptake inhibitions facilitate ventilation in rats.

Authors:  E C Monteiro; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

Review 5.  Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS).

Authors:  Julian M Stewart
Journal:  J Pediatr       Date:  2004-12       Impact factor: 4.406

6.  Differences between automatically detected and steady-state fractional flow reserve.

Authors:  Tobias Härle; Sven Meyer; Felix Vahldiek; Albrecht Elsässer
Journal:  Clin Res Cardiol       Date:  2015-07-25       Impact factor: 5.460

7.  Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

Authors:  G A Rongen; S C Brooks; S i Ando; B L Abramson; J S Floras
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

8.  Role of endogenous adenosine in vasovagal syncope.

Authors:  M Sinkovec; A Grad; P Rakovec
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

Review 9.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

10.  Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance.

Authors:  Theodoros D Karamitsos; Ntobeko A B Ntusi; Jane M Francis; Cameron J Holloway; Saul G Myerson; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-16       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.